STOCK TITAN

Clarivate Plc - CLVT STOCK NEWS

Welcome to our dedicated news page for Clarivate Plc (Ticker: CLVT), a resource for investors and traders seeking the latest updates and insights on Clarivate Plc.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Clarivate Plc's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Clarivate Plc's position in the market.

Rhea-AI Summary
Clarivate, in partnership with Global Healthcare Intelligence, launches a LatAm market tracking solution to analyze the medical device market in Brazil, Colombia, Argentina, Chile, Peru, and Ecuador. The solution offers real-time tracking of over 100 medical devices and 500 product categories, catering to the $10 billion annual market in Latin America. Key players in the region account for 89% of the market, highlighting LatAm's significance in the global healthcare industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
partnership
-
Rhea-AI Summary
Clarivate Plc (CLVT) will announce its first-quarter 2024 financial results on May 8, 2024, followed by a conference call and webcast. Interested parties can access the earnings supplement and financial information on the Clarivate investor website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.97%
Tags
conferences earnings
-
Rhea-AI Summary
Clarivate Plc executives discuss growth initiatives, including Generative AI strategies, in recent investor conferences. CFO and segment Presidents highlight leveraging content, solutions, and long-term growth potential.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.67%
Tags
none
Rhea-AI Summary
Clarivate Plc (CLVT) acquires assets of MotionHall, a Silicon Valley technology start-up, to enhance its Life Sciences & Healthcare strategy with industry vertical AI solutions. The acquisition aims to accelerate roadmaps, improve market assessments, and introduce new Business Development & Licensing Enterprise Workbench.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.54%
Tags
-
Rhea-AI Summary
Clarivate Plc announces the launch of the final video in the Clarivate in the Age of AI webinar series, focusing on Intellectual Property. Gordon Samson, President of Intellectual Property, discusses the company's strategy, AI initiatives, and commitment to adding value for customers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.67%
Tags
AI
-
Rhea-AI Summary
Clarivate Plc announces the launch of a webinar series focusing on AI initiatives in the Life Sciences & Healthcare segment. Henry Levy, President of Life Sciences & Healthcare, discusses the company's market position, growth strategy, and Generative AI utilization.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.14%
Tags
AI
Rhea-AI Summary
Clarivate Plc executives to present at BofA Securities 2024 Information & Business Services Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.14%
Tags
conferences
-
Rhea-AI Summary
Clarivate Plc announces the launch of Clarivate in the Age of AI video webinar series led by segment Presidents. Bar Veinstein discusses leveraging Generative AI to drive growth in the global academia market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2%
Tags
AI
-
Rhea-AI Summary
Clarivate Plc unveils its 2024 list of Top 100 Global Innovators™, with Samsung Electronics topping the ranking. The report highlights key trends, geographical spread, and industry sectors shaping the global innovation landscape.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.71%
Tags
none
Rhea-AI Summary
Exor becomes a long-term investor in Clarivate, acquiring a 10.1% shareholding with the option to increase it to 17.5%. Suzanne Heywood nominated for election to Clarivate's Board of Directors. Positive outlook expressed by Clarivate's CEO and Board members regarding Exor's investment.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.12%
Tags
management
Clarivate Plc

NYSE:CLVT

CLVT Rankings

CLVT Stock Data

4.72B
404.04M
16.65%
92.2%
5.52%
Data Processing, Hosting, and Related Services
Information
Link
United Kingdom
160 Blackfriars Road

About CLVT

clarivate analytics is the global leader in providing trusted insights and analytics to accelerate the pace of innovation. we offer some of the most trusted brands across the innovation lifecycle, including web of science™, cortellis™, derwent™, compumark™, markmonitor® and techstreet™. organizations and researchers rely on the curated knowledge bases from clarivate for information about scientific and academic research, patent analytics, pharmaceutical and biotech intelligence and ip management. an independent company with over 4,000 employees and operations in more than 100 countries, clarivate is on a bold entrepreneurial mission to help radically reduce the time from new ideas to life-changing innovations. for more information, please visit clarivate.com.